Marketed in Spain the first medication derived from cannabis to treat refractory epilepsy
From September 2021, Cannabidiol (CBD) will be marketed in Spain as the first medication used to treat refractory epilepsy, which does not respond we1
From September 2021, Cannabidiol (CBD) will be marketed in Spain as the first medication used to treat refractory epilepsy, which does not respond we1
Long COVID has already been defined as a disease by WHO. It usually appears three months after the onset of infection. Studies show that 80% of pati1
A study carried out entirely at the Hospital Clínic - IDIBAPS has determined that mitochondrial function in the metabolism of white blood cells is cl1
The COVID-19 pandemic has emphasised the importance of vaccination. Every year the public faces the influenza virus, which causes more than 200,000 d1
The results show that people with HIV with chronic comorbidities and an unsuppressed HIV viral load could be at greater risk of developing severe COV1
Long COVID involves significant limitations in terms of quality of life, including among young people. One of the sequelae that has the greatest impa1
The flash system for continuous glucose monitoring (CGM) in interstitial fluid has been a major breakthrough for people with diabetes, in terms of bo1
Physical activity reduces the risk of developing many non-communicable diseases, such as cardiovascular disease or cancer. Recent studies have shown1
In recent years, the number of women of childbearing age undergoing bariatric surgery as treatment for obesity has increased. Among the scientific co1
Researchers at Hospital Clínic-IDIBAPS have developed the first diagnostic tool for Foetal Alcohol Spectrum Disorder (FASD) based on artificial intel1